Description
Mitochondrial Signaling, Lean Mass Preservation, and Neuroendocrine Support
This advanced bundle builds on Stage 2’s receptor logic by introducing non-overlapping agents that target mitochondrial biogenesis, NAD⁺ elevation, myostatin inhibition, GH fragment signaling, and sleep-phase recovery. Designed for researchers seeking to explore multi-pathway metabolic extension while preserving lean mass and modulating neuroendocrine tone.
Included Peptides
- SLU‑PP‑332 – 10mg
- 5‑Amino‑1MQ – 10mg
- ACE‑031 – 1mg
- AOD‑9604 – 5mg
- DSIP – 5mg
- Reconstitution Water – 10ml ×2
Mechanistic Highlights
- SLU‑PP‑332: Activates PPARδ and ERRα pathways, mimicking aerobic exercise at the mitochondrial level
- 5‑Amino‑1MQ: Inhibits NNMT, elevates NAD⁺, and supports insulin sensitivity and fat metabolism
- ACE‑031: Myostatin decoy receptor; promotes lean mass retention during metabolic acceleration
- AOD‑9604: GH fragment with lipolytic signaling, independent of IGF‑1 elevation
- DSIP: Neuroendocrine modulator; supports sleep architecture, ACTH regulation, and recovery-phase tone
Stacking Logic
- No receptor overlap with Stage 1 or Stage 2 compounds
- Ideal for post-GLP‑1 and GH axis evaluation
- DSIP introduces nighttime recovery support without interfering with daytime metabolic agents
- Dual reconstitution vials included for multi-compound preparation
All compounds are provided strictly for laboratory research and analytical reference. No claims are made regarding human outcomes. Researchers are encouraged to document each stage independently and consult available reference guides for reconstitution and storage.

Reviews
There are no reviews yet.